NewsRoom Articles - Page 1328 of 1423

MondayMar 13, 2017 10:00 am

Cogentix Medical, Inc. (NASDAQ: CGNT) Starts Presentation at 29th Annual ROTH Conference

Cogentix Medical (NASDAQ: CGNT) is a global medical device company. The company is headquartered in Minnetonka, Minnesota, with additional operations in New York, Massachusetts, The Netherlands and the United Kingdom. Cogentix designs, develops, manufactures and markets products for flexible endoscopy using its PrimeSight, providing users with efficient and cost effective endoscope turnover while enhancing patient safety. The company also commercializes the Urgent® PC Neuromodulation System, an FDA-cleared device that delivers percutaneous tibial nerve stimulation for the office-based treatment of overactive bladder (OAB). Additionally, the company offers Macroplastique®, an injectable urethral bulking agent for the treatment of adult female stress urinary incontinence primarily due to intrinsic sphincter deficiency.…

MondayMar 13, 2017 10:00 am

Lakeland Industries, Inc. (NASDAQ: LAKE) Starts Presentation at 29th Annual ROTH Conference

Lakeland Industries (NASDAQ: LAKE) manufactures and sells a range of safety garments and accessories for the industrial and public protective clothing. The company offers limited use/disposable protective clothing; high-end chemical protective suits to provide protection from highly concentrated and hazardous chemical and biological toxins; and firefighting and heat protective apparel, which is used for the maintenance of high temperature equipment, and for military and airport crash and rescue teams. For more information, visit the company’s website at www.lakeland.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services and a full array of social communication solutions. As a…

MondayMar 13, 2017 10:00 am

Viking Therapeutics, Inc. (NASDAQ: VKTX) Starts Presentation at 29th Annual Roth Conference

Viking Therapeutics (NASDAQ: VKTX) is a clinical-stage biopharmaceutical company that focuses on the development of therapies for metabolic and endocrine disorders. Its lead clinical program includes VK0612, an orally available drug candidate for the treatment of Type 2 diabetes. The company is also developing VK5211, an orally available drug candidate, which is in a phase II clinical trial for acute rehabilitation following non-elective hip fracture surgery. In addition, it is developing VK0214, a novel liver-selective thyroid hormone receptor beta agonist for lipid disorders, such as dyslipidemia and nonalcoholic steatohepatitis, as well as VK2809, an orally available, tissue, and receptor-subtype selective…

MondayMar 13, 2017 10:00 am

Conatus Pharmaceuticals, Inc. (NASDAQ: CNAT) Starts Presentation at 29th Annual ROTH Conference

Conatus Pharmaceuticals (NASDAQ: CNAT) is a biotechnology company focused on the development and commercialization of novel medicines to treat liver disease. The company is developing its lead compound, emricasan, for the treatment of patients with chronic liver disease. Emricasan is designed to reduce the activity of enzymes that mediate inflammation and apoptosis. Conatus believes that by reducing the activity of these enzymes, emricasan has the potential to interrupt the disease progression across the spectrum of liver disease. For more information, visit the company’s website www.conatuspharma.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services and a…

MondayMar 13, 2017 10:00 am

Clean Diesel Technologies, Inc. (NASDAQ: CDTI) Starts Presentation at 29th Annual ROTH Conference

Clean Diesel Technologies (NASDAQ: CDTI) develops advanced materials technology for the emissions control market. The company’s proprietary technologies provide sustainable solutions to reduce hazardous emissions, increase energy efficiency and lower the carbon intensity of on- and off-road combustion engine systems. With a continuing focus on innovation-driven commercialization and global expansion, CDTi’s Powder-to-Coat (P2C™) technology exploits the company’s high-performance, advanced low-platinum group metal emission reduction catalysts. Key technology platforms include Mixed Phase Catalyst (MPC®), Base Metal Activated Rhodium Support (BMARS™), Synergized PGM (SPGM™), Zero PGM (ZPGM™) and Spinel™. For more information, visit the company’s website www.cdti.com. About NetworkNewsWire NetworkNewsWire (NNW) provides…

MondayMar 13, 2017 10:00 am

Research Solutions Inc. (RSSS) Starts Presentation at 29th Annual Roth Conference

Research Solutions (OTC: RSSS) provides on-demand access to scientific, technical and medical (STM) information for life science companies, academic institutions and other research intensive organizations in the United States and internationally. The company offers Article Galaxy, a cloud-based software-as-a-service solution, which provides customers with access to the published STM content that includes approximately 70 million existing STM articles, as well as approximately 1 million newly published STM articles each year. Its Article Galaxy allows customers to find and download in digital format STM articles that are critical to their research, as well as facilitates customers’ compliance with applicable copyright laws.…

MondayMar 13, 2017 10:00 am

Diamondback Energy, Inc. (NASDAQ: FANG) Starts Presentation at 29th Annual ROTH Conference

Diamondback Energy (NASDAQ: FANG) is an independent oil and natural gas company headquartered in Midland, Texas. The company is focused on the acquisition, development, exploration and exploitation of unconventional, onshore oil and natural gas reserves in the Permian Basin in West Texas. Diamondback’s activities are primarily focused on the horizontal exploitation of multiple intervals within the Wolfcamp, Spraberry, Clearfork, Bone Spring and Cline formations. For more information, visit the company’s website at www.diamondbackenergy.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services and a full array of social communication solutions. As a multifaceted financial news and distribution…

MondayMar 13, 2017 9:00 am

GreeneStone Healthcare Corp. (GRST) Bringing Unique Substance Abuse Recovery Approach to Florida

Substance abuse and addiction remain a serious problem across the United States, generating more than $700 billion a year in expenses related to health care, crime, work productivity and more, according to the National Institute on Drug Abuse (http://nnw.fm/9IpUl). Abuse of tobacco, illicit drugs and alcohol remains high, along with the number of prescription drug users nationwide. Unfortunately, not all people suffering from a substance abuse problem get the treatment they need, or perhaps access to any kind of treatment at all, with potentially lethal consequences. GreeneStone Healthcare Corp. (OTCQB: GRST), a Canadian-founded provider of healthcare services, with a focus…

MondayMar 13, 2017 8:35 am

Investors Hub Launches In-App Trading Execution

ADVFN plc (OTC: IHUBY) has joined forces with TradeIt to allow Investors Hub (iHub) and ADVFN users to send trades directly to major US brokerages from within iHub and ADVFN iOS apps. ADVFN, known in the investing community for its cutting-edge data products and the most popular stock forum in the world, has already seen a rise in the popularity of its mobile offering; in-app execution is expected to accelerate this. View screenshot: http://nnw.fm/ihub-app-screenshot "Our user base relies on our aggregated newsfeeds, forums and live market data to generate trade ideas," said Matthew Collom, Director of ADVFN, "This partnership gives…

FridayMar 10, 2017 3:22 pm

The Diversified Domain of Easton Pharmaceuticals, Inc. (EAPH)

Drug development. Medical marijuana. Female diagnostics and treatments. These high-growth industries and sectors are the focal points of Easton Pharmaceuticals, Inc.’s (OTC: EAPH) operations. A diversified and specialty company based in Canada, Easton’s operation spans multiple pharmaceutical sectors and other emergent industries, including the medical marijuana market. In its day-to-day operations, the company balances three mission goals: It develops and acquires drugs, diagnostics and treatment products that build shareholder value. It delivers safe, effective and proven products that improve the health and well-being of men and women across global jurisdictions. It builds and capitalizes on fast-growing and promising industries and…

Financial news and publishing for public and private companies

Contact us: 512.354.7000

Cogentix Medical, Inc. (NASDAQ: CGNT) Starts Presentation at 29th Annual ROTH Conference

Lakeland Industries, Inc. (NASDAQ: LAKE) Starts Presentation at 29th Annual ROTH Conference

Viking Therapeutics, Inc. (NASDAQ: VKTX) Starts Presentation at 29th Annual Roth Conference

Conatus Pharmaceuticals, Inc. (NASDAQ: CNAT) Starts Presentation at 29th Annual ROTH Conference

Clean Diesel Technologies, Inc. (NASDAQ: CDTI) Starts Presentation at 29th Annual ROTH Conference

Research Solutions Inc. (RSSS) Starts Presentation at 29th Annual Roth Conference

Diamondback Energy, Inc. (NASDAQ: FANG) Starts Presentation at 29th Annual ROTH Conference

GreeneStone Healthcare Corp. (GRST) Bringing Unique Substance Abuse Recovery Approach to Florida

Investors Hub Launches In-App Trading Execution

The Diversified Domain of Easton Pharmaceuticals, Inc. (EAPH)

NetworkNewsWire Currently Accepts

NetworkNewsWire

Financial news and publishing for public and private companies

Contact us: 512.354.7000

NetworkNewsWire Currently Accepts

Company Search

Site Search